Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.74 CNY | +3.57% |
|
-4.40% | -30.68% |
Kurzporträt
Umsatz nach Geschäftsbereich
CNY in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Chemical Medicine
95,9
%
| 2 967 | 95,5 % | 2 517 | 95,9 % | -15.15% |
Traditional Chinese Medicine
3,8
%
| 135 | 4,3 % | 101 | 3,8 % | -24.96% |
Other Business
0,3
%
| 5 | 0,2 % | 7 | 0,3 % | +37.80% |
Others
0,0
%
| 2 | 0,1 % | 1 | 0,0 % | -52.00% |
Umsatz je Region
CNY in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
China
99,9
%
| 3 102 | 99,8 % | 2 624 | 99,9 % | -15.42% |
Abroad
0,1
%
| 6 | 0,2 % | 2 | 0,1 % | -61.30% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Lei Feng Guo
CEO | Chief Executive Officer | 51 | 11.11.22 |
Zuo Zhe Ji
DFI | Director of Finance/CFO | 47 | 18.12.20 |
Jia Feng Zang
CTO | Chief Tech/Sci/R&D Officer | 48 | 27.04.21 |
Kang Zhou
BRD | Director/Board Member | 40 | 18.04.18 |
Xiu Qiang Diao
BRD | Director/Board Member | 47 | 01.11.12 |
Xue Long Bai
IRC | Investor Relations Contact | - | - |
Ran Wang
LAW | General Counsel | 39 | 26.12.22 |
Yue Yin Liu
SEC | Corporate Secretary | 38 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jin Hu
CHM | Chairman | 48 | 22.07.20 |
Min Pan
BRD | Director/Board Member | 53 | 20.12.22 |
Xiu Qiang Diao
BRD | Director/Board Member | 47 | 01.11.12 |
Xiao Dan Zhang
BRD | Director/Board Member | 49 | 20.12.22 |
Lei Feng Guo
CEO | Chief Executive Officer | 51 | 11.11.22 |
Yue Yin Liu
SEC | Corporate Secretary | 38 | - |
Li Na Wang
BRD | Director/Board Member | 46 | - |
Kang Zhou
BRD | Director/Board Member | 40 | 18.04.18 |
Zuo Zhe Ji
DFI | Director of Finance/CFO | 47 | 18.12.20 |
Ming Hui Jiang
BRD | Director/Board Member | 46 | 20.12.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 2 270 513 950 | 1 983 655 317 ( 87,37 %) | 0 | 87,37 % |
Unternehmenskontakt
Harbin Gloria Pharmaceuticals Co., Ltd.
Building 28, Ronghui Garden Yuhua Road, Area B
101318, Beijing
+86 451 5735 1368
http://www.gloria.cc![Straße Harbin Gloria Pharmaceuticals Co., Ltd(002437)](https://cdn.zonebourse.com/static/address/7461300.png)
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
-30.68% | 544 Mio. | |
+20.39% | 43.67 Mrd. | |
+26.21% | 22.79 Mrd. | |
+22.17% | 15.45 Mrd. | |
+18.82% | 14.29 Mrd. | |
+53.37% | 12.83 Mrd. | |
-0.05% | 6.79 Mrd. | |
-11.88% | 6.52 Mrd. | |
-8.87% | 5.73 Mrd. | |
+12.62% | 5.59 Mrd. |
- Börse
- Aktien
- 002437 Aktie
- Unternehmen Harbin Gloria Pharmaceuticals Co., Ltd